FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014094733> ?p ?o ?g. }

• W3014094733 endingPage "117631" @default.
• W3014094733 startingPage "117631" @default.
• W3014094733 abstract "Initially, the selective COX-2 inhibitors were developed as safer alternatives to the conventional NSAIDs, but later on, most of them were withdrawn from the market due to the risk of heart attack and stroke. Celecoxib, the first selective COX-2 inhibitor, was approved by the Food and Drug Administration (FDA) in December 1998 and was taken back from the market in 2004. Since then, many coxibs have been discontinued one by one due to adverse cardiovascular events. United States (US), Australian and European authorities related to Therapeutic Goods Administration (TGA) implemented the requirements to carry the Black box warning on the labels of COX-2 drugs highlighting the risks of serious cardiovascular events. These facts encouraged the researchers to explore them well and find out the biochemical basis behind the cardiotoxicity. From the last few decades, the molecular mechanisms behind the coxibs have regained the attention, especially the specific structural features of the selective COX-2 inhibitors that are associated with cardiotoxicity. This review discusses the key structural features of the selective COX-2 inhibitors and underlying mechanisms that are responsible for the cardiotoxicity. This report also unfolds different strategies that have been reported in the last 10 years to combat the problem of selective COX-2 inhibitors mediated cardiotoxicity." @default.
• W3014094733 created "2020-04-10" @default.
• W3014094733 creator A5004042220 @default.
• W3014094733 creator A5014833878 @default.
• W3014094733 creator A5016343058 @default.
• W3014094733 creator A5024604731 @default.
• W3014094733 creator A5027074814 @default.
• W3014094733 date "2020-06-01" @default.
• W3014094733 modified "2023-10-12" @default.
• W3014094733 title "Structural investigation on the selective COX-2 inhibitors mediated cardiotoxicity: A review" @default.
• W3014094733 cites W1565253767 @default.
• W3014094733 cites W1926261341 @default.
• W3014094733 cites W1950491041 @default.
• W3014094733 cites W1965992514 @default.
• W3014094733 cites W1977473142 @default.
• W3014094733 cites W1978082123 @default.
• W3014094733 cites W1979107796 @default.
• W3014094733 cites W1980933092 @default.
• W3014094733 cites W1999124449 @default.
• W3014094733 cites W2001162433 @default.
• W3014094733 cites W2002355985 @default.
• W3014094733 cites W2003748753 @default.
• W3014094733 cites W2004916700 @default.
• W3014094733 cites W2009486610 @default.
• W3014094733 cites W2009724412 @default.
• W3014094733 cites W2009978158 @default.
• W3014094733 cites W2010899039 @default.
• W3014094733 cites W2011384588 @default.
• W3014094733 cites W2011513325 @default.
• W3014094733 cites W2011861566 @default.
• W3014094733 cites W2012801178 @default.
• W3014094733 cites W2012930217 @default.
• W3014094733 cites W2017150228 @default.
• W3014094733 cites W2017203125 @default.
• W3014094733 cites W2019417284 @default.
• W3014094733 cites W2020563114 @default.
• W3014094733 cites W2027451784 @default.
• W3014094733 cites W2030087792 @default.
• W3014094733 cites W2030793740 @default.
• W3014094733 cites W2030850720 @default.
• W3014094733 cites W2034468337 @default.
• W3014094733 cites W2035037307 @default.
• W3014094733 cites W2039131678 @default.
• W3014094733 cites W2044184763 @default.
• W3014094733 cites W2050827759 @default.
• W3014094733 cites W2054521948 @default.
• W3014094733 cites W2061533176 @default.
• W3014094733 cites W2062763066 @default.
• W3014094733 cites W2063408001 @default.
• W3014094733 cites W2066395665 @default.
• W3014094733 cites W2069355129 @default.
• W3014094733 cites W2070360923 @default.
• W3014094733 cites W2070398215 @default.
• W3014094733 cites W2076000596 @default.
• W3014094733 cites W2080513230 @default.
• W3014094733 cites W2080674779 @default.
• W3014094733 cites W2089107052 @default.
• W3014094733 cites W2094761607 @default.
• W3014094733 cites W2095001632 @default.
• W3014094733 cites W2127161627 @default.
• W3014094733 cites W2129393568 @default.
• W3014094733 cites W2130900386 @default.
• W3014094733 cites W2135946423 @default.
• W3014094733 cites W2141783462 @default.
• W3014094733 cites W2150065588 @default.
• W3014094733 cites W2151225936 @default.
• W3014094733 cites W2151425074 @default.
• W3014094733 cites W2154476123 @default.
• W3014094733 cites W2158131645 @default.
• W3014094733 cites W2162364577 @default.
• W3014094733 cites W2163426803 @default.
• W3014094733 cites W2166976731 @default.
• W3014094733 cites W2330496155 @default.
• W3014094733 cites W2564342551 @default.
• W3014094733 cites W2792578312 @default.
• W3014094733 cites W2800945491 @default.
• W3014094733 cites W2888408260 @default.
• W3014094733 cites W2949972563 @default.
• W3014094733 cites W2967572936 @default.
• W3014094733 cites W2969159914 @default.
• W3014094733 cites W2970157778 @default.
• W3014094733 cites W4254058912 @default.
• W3014094733 doi "https://doi.org/10.1016/j.lfs.2020.117631" @default.
• W3014094733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32251635" @default.
• W3014094733 hasPublicationYear "2020" @default.
• W3014094733 type Work @default.
• W3014094733 sameAs 3014094733 @default.
• W3014094733 citedByCount "40" @default.
• W3014094733 countsByYear W30140947332020 @default.
• W3014094733 countsByYear W30140947332021 @default.
• W3014094733 countsByYear W30140947332022 @default.
• W3014094733 countsByYear W30140947332023 @default.
• W3014094733 crossrefType "journal-article" @default.
• W3014094733 hasAuthorship W3014094733A5004042220 @default.
• W3014094733 hasAuthorship W3014094733A5014833878 @default.
• W3014094733 hasAuthorship W3014094733A5016343058 @default.
• W3014094733 hasAuthorship W3014094733A5024604731 @default.
• W3014094733 hasAuthorship W3014094733A5027074814 @default.

• next